Evoke Pharma, Inc.

Evoke Pharma, Inc.

EVOK
Evoke Pharma, Inc.US flagNASDAQ Capital Market
11.00
USD
+11.00
- -
18.95MMarket Cap

Evoke Pharma, Inc. (EVOK) Stock Split History

Learn about Evoke Pharma, Inc.'s most recent 1-for-12 basis stock split on August 01, 2024. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Evoke Pharma, Inc.'s most recent stock split

Split Date: 2024-08-01
Split Ratio: 1:12
Price Before Split: $0.41
Price After Split: $0.03

Developer API

Get EVOK split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/EVOK

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 12.00 times fewer shares (a 1:12 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Evoke Pharma, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-08-011:12Yes$0.41$0.03
2022-05-231:12Yes$0.23$0.02

About Evoke Pharma, Inc.

Company overview and industry information

Evoke Pharma, Inc. (EVOK) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 1-for-12 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Drug Manufacturers - Specialty & Generic
Go to Evoke Pharma, Inc. Summary

Last updated: 7/8/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.